Scope of Practice Review slammed over ‘flawed’ proposal to cash out MBS care plans
The Scope of Practice Review is going beyond its remit by suggesting “cashing out” a string of GP programs to fund multidisciplinary care teams, the…
Tag: Regulation
MDOs not ‘currently’ planning to restrict medicinal cannabis prescribing cover
Three of Australia’s MDOs report no plans to restrict cover for medicinal cannabis prescribing despite MDA National deeming it an “unusual practice”. Last month, AusDoc reported that…
Junior doctor challenges AHPRA over registration fees and parental leave
When third-year oncology registrar Dr Belle Sasse took maternity leave last year, she took non-practising status to cut her registration fees to around $200 a…
Expand funding for GLP-1 RAs and continuous glucose monitors: federal diabetes inquiry
Patients with diabetes should have access to longer subsidised appointments with allied health professionals and greater access to GLP-1 receptor agonists, a parliamentary inquiry has…
Doctors suspended after ‘complete dereliction’ of IMG supervision rules
An IMG has been suspended, along with two other doctors, after she was allowed to treat patients unsupervised while on provisional registration — even after…
‘AHPRA investigated me over a patient I had never met’
When this GP received an AHPRA notification, two things stood out. It used the wrong practice address, and the GP had never treated the patient.…
GLP-1 RAs slapped with ileus warning after TGA investigation
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
Hundreds more GP practices offered limited protection from payroll tax — but only if they bulk-bill
GP practices in NSW are being offered payroll tax relief provided they bulk-bill at least 70% of patient consults. The State Government says it will…
Chiropractic board reinstates ban on spinal manipulation in babies but for how long?
The rapid unravelling of the Chiropractic Board of Australia’s position on spinal manipulation in babies is about more than regulatory red faces. The board initially…
How Novo Nordisk lobbied AHPRA and the TGA to get compounded semaglutide banned
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
